“Global Empty Capsules Market set to grow to $2.8bn by 2025” says new Visiongain report

23 January 2020
Pharma

Visiongain has launched a new pharma report Global Empty Capsules Market and Industry Forecast 2020-2030: Gelatin Capsules, Non-gelatin Capsules, Pig Skin Gelatin, Bovine Derived Gelatin, Bone Meal Gelatin, Hydroxypropyl Methyl Cellulose (HPMC), Pullulan, Starch Material, Antibiotic & Antibacterial Drugs, Vitamins & Dietary Supplements, Cough & Cold Preparations, Anti-inflammatory Drugs, Cardiovascular Drugs, Antacid & Antiflatulent Drugs, Antianemic Drugs, Pharmaceutical Industry, Neutraceutical Industry, Cosmetics Industry, Clinical Research Laboratories.

The empty capsules market is a highly competitive and diverse market with immense potential for growth. The growth drivers of this market are ageing population, increasing applications in the pharmaceutical and nutraceutical industries, increasing demand for non-gelatin/HPMC capsules in nutraceutical industry, and market development in emerging countries due to low manufacturing advantage.

The lead analyst of the report commented "The non-gelatin capsules segment is estimated to grow at the highest CAGR during the forecast period. Strict government regulations, dietary sensitivity of patients, and drug incompatibilities with gelatin capsules are the major factors driving the growth of the non-gelatin capsules segment. the growing demand for non-gelatin-based capsules and the rapidly expanding pharmaceutical industry in emerging countries such as India and China offer significant growth opportunities for players in this market."

Leading companies featured in the report include ACG Worldwide, Bright Pharmacaps Inc., CapsCanada Corporation, Capsugel (Lonza), Healthcaps India Ltd., Medicaps Ltd., Natural Capsules Limited and other companies.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Clinical Trials Market Report 2020-2030

With the growing burden of rare diseases around the world, there has been a rise and advancement in the therapy development of these types of diseases. While the fact remains that over 90% of these diseases lack approval for treatment and the total number of terminal rare diseases to receive the first treatment every year remains low.

01 July 2020

Read

Visiongain Publishes Clinical Risk Grouping Solutions Market Report 2020-2030

The market growth is attributed to the growing adoption of big data and AI in data management and monitoring of clinical information in health care.

01 July 2020

Read

Visiongain Publishes Clinical Perinatal Software Market Report 2020-2030

Various research studies are currently underway, which are expected to create a competitive advantage for manufacturers to develop new and innovative and advanced software that is expected to provide a variety of additional opportunities in the perinatal clinical software market.

01 July 2020

Read

Visiongain publishes Clinical Laboratory Tests Market Report 2020-2030

Growing investment in target diagnosis of cardiovascular disorders, TB and diabetes drives demand for clinical laboratory testing. Clinical lab tests help in diagnosing mellitus diabetes. According to the International Diabetes Federation article published in 2019, some 463 million adults were diabetic, and it is estimated that it will reach 700 million worldwide by 2045.

01 July 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever